(Q34272523)

1 August 2017

1 reference

title

Clinical aspects and pathophysiology of narcolepsy (English)

1 reference

1 August 2017

0 references

1 reference

3

Jacques Montplaisir

1 reference

1 August 2017

1

Yves Dauvilliers

1 reference

1 August 2017

Michel Billiard

2

1 reference

1 August 2017

1 November 2003

1 reference

1 August 2017

Clinical Neurophysiology

1 reference

1 August 2017

114

1 reference

1 August 2017

11

1 reference

1 August 2017

2000-2017

1 reference

Does memory impairment exist in narcolepsy-cataplexy?

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Automobile accidents in patients with sleep disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Narcolepsy associated with lesions of the diencephalon.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Exacerbation of human cataplexy by prazosin.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Dopamine‐receptor autoradiography of human narcoleptic brain

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

DR2?NEGATIVE NARCOLEPSY

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Symptomatic narcolepsies

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Family studies in narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Leptin: the voice of the adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Narcolepsy: cholinergic receptor changes in an animal model.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Effects of bromocriptine on periodic limb movements in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Brain dopamine receptor levels elevated in canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: a laboratory perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Psychosocial impact of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Narcolepsy in children

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Correlates of sleep latency on the multiple sleep latency test in a clinical population.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

1 reference

7 January 2021

Increased prevalence of obesity in narcoleptic patients and relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Increased frequency of migraine in narcoleptic patients: a confirmatory study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Circadian rhythms in narcolepsy: studies on a 90 minute day.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Age at onset of narcolepsy in two large populations of patients in France and Quebec.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

MAO-A and COMT polymorphisms and gene effects in narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Severity of narcolepsy among French of different ethnic origins (south of France and Martinique).

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Cholinergic mechanisms and cataplexy in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

The nature of the narcoleptic sleep attack

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Monoaminergic mechanisms and experimental cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Canine narcolepsy is associated with an elevated number of alpha 2-receptors in the locus coeruleus.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

1 reference

7 January 2021

HLA-DR2 and narcolepsy: not all narcoleptic-cataplectic patients are DR2

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Investigations into the neurologic basis of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Viloxazine hydrochloride in narcolepsy: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Familial patterns of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Narcolepsy in prepubertal children

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

1 reference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Treatment of narcolepsy with imipramine (tofranil) and desmethylimipramine (pertofran)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Acetylcholine as a brain state modulator: triggering and long-term regulation of REM sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Clinical and polysomnographic features in DQB1*0602 positive and negative narcolepsy patients: results from the modafinil clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Dopamine D2-receptors in human narcolepsy: a SPECT study with 123 I-IBZM

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Selegiline in the treatment of narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Striatal dopamine D2 receptors in patients with narcolepsy measured with PET and 11C-raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Muscarinic cholinergic receptors and the canine model of narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Spontaneous food choice in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Genetic markers in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Fluoxetine in the treatment of cataplexy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Narcolepsy associated with other central nervous system disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

DQ (rather than DR) gene marks susceptibility to narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Motor dyscontrol in sleep of narcoleptic patients (a lifelong development?).

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Narcolepsy: Biogenic Amine Deficits in an Animal Model

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Control of food intake via leptin receptors in the hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Genetic and familial aspects of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Effect of alpha 1-adrenoceptors blockade with prazosin in canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Role of central alpha-1 adrenoceptors in canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Evidence for multiple [3H]prazosin binding sites in canine brain membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Central alpha 1 adrenoceptor subtypes in narcolepsy-cataplexy: a disorder of REM sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Narcolepsy and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Reduction of REM sleep latency associated with HLA-DQB1*0602 in normal adults

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

CNS monoamines and their metabolites in canine narcolepsy: a replication study.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Narcolepsy-cataplexy in a female dog

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Narcolepsy and idiopthic hypersomnia: biogenic amines and related compounds in CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Periodic leg movements are not more prevalent in insomnia or hypersomnia but are specifically associated with sleep disorders involving a dopaminergic impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

The positive diagnosis of narcolepsy and narcolepsy's borderland.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

HLA and narcolepsy in a German population

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Linkage of human narcolepsy with HLA association to chromosome 4p13-q21

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Pharmacological aspects of human and canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Hypocretin (orexin) deficiency in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Dynamics of slow wave activity in narcoleptic patients under bed rest conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Prevalence of narcolepsy symptomatology and diagnosis in the European general population.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Mazindol in the treatment of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Neurons containing hypocretin (orexin) project to multiple neuronal systems

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Cholinergic mechanisms in canine narcolepsy--I. Modulation of cataplexy via local drug administration into the pontine reticular formation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Cholinergic mechanisms in canine narcolepsy--II. Acetylcholine release in the pontine reticular formation is enhanced during cataplexy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Excessive daytime sleepiness in man: Multiple sleep latency measurement in narcoleptic and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Chronic oral administration of CG-3703, a thyrotropin releasing hormone analog, increases wake and decreases cataplexy in canine narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Positron emission tomography study of human narcolepsy: No increase in striatal dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Hypocretin levels in sporadic and familial cases of canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Protriptyline: an effective agent in the treatment of the narcolepsy- cataplexy syndrome and hypersomnia

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Increased body-mass index in patients with narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Reduced leptin levels in human narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Central nervous system control of food intake

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Solving the mysteries of narcolepsy: the hypocretin story

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Distribution and quantification of immunoreactive orexin A in rat tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Reduced number of hypocretin neurons in human narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Studies in psychophysiology of dreams. III. The dream of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

The prevalence of narcolepsy among Chinese in Hong Kong.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Dopaminergic role in stimulant-induced wakefulness.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

Treatment of narcolepsy with ritalin

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900203-7

7 January 2021

10.1016/S1388-2457(03)00203-7

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

14580598